Biotech giant @ResMed has acquired German healthcare software developer @MEDIFOXDAN 🎉 @ResMed's CEO Mick Farrell: "We see it as a great opportunity to extend our capabilities from just being a U.S. SaaS business to being a global one" 🇺🇸🤝🇩🇪 #GoGlobalSD t.co/fzneY8h4Pb